Open access peer-reviewed chapter

Four Aspects of Autoimmunity and How to Regain Tolerance to Self From an Autoimmune Disease Utilizing the Modified Vaccination Technique

By Arpad Z. Barabas, Chad D. Cole, Arpad D. Barabas, Rene Lafreniere and Donald M. Weir

Submitted: November 9th 2010Reviewed: April 20th 2011Published: November 14th 2011

DOI: 10.5772/20668

Downloaded: 1173

© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Arpad Z. Barabas, Chad D. Cole, Arpad D. Barabas, Rene Lafreniere and Donald M. Weir (November 14th 2011). Four Aspects of Autoimmunity and How to Regain Tolerance to Self From an Autoimmune Disease Utilizing the Modified Vaccination Technique, Autoimmune Disorders - Current Concepts and Advances from Bedside to Mechanistic Insights, Fang-Ping Huang, IntechOpen, DOI: 10.5772/20668. Available from:

chapter statistics

1173total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Parasitic Helminths as Potential Therapeutic Agents Against Autoimmune Disorders

By Yoshio Osada

Related Book

First chapter

New Challenges for Old Diseases: The Impact of -Omics Technologies in the Understanding of Allergic Diseases

By Blanca Cárdaba, Miriam Aguerri, David Calzada and Carlos Lahoz

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us